Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
0.7060
+0.0120 (1.73%)
At close: Apr 2, 2025, 4:00 PM
0.7255
+0.0195 (2.76%)
After-hours: Apr 2, 2025, 5:02 PM EDT

Spero Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
39567890518527
Upgrade
Market Cap Growth
-27.92%-27.92%-13.02%-82.69%-1.83%186.63%
Upgrade
Enterprise Value
-9-16-1046401408
Upgrade
Last Close Price
0.711.031.471.7316.0119.39
Upgrade
PE Ratio
--3.42---
Upgrade
PS Ratio
0.801.170.751.6728.3556.50
Upgrade
PB Ratio
0.841.220.731.185.863.99
Upgrade
P/TBV Ratio
1.221.220.731.185.863.99
Upgrade
EV/Sales Ratio
--0.8621.9843.73
Upgrade
Debt / Equity Ratio
0.090.090.050.090.630.06
Upgrade
Debt / EBITDA Ratio
--0.19---
Upgrade
Asset Turnover
0.330.330.680.360.110.07
Upgrade
Quick Ratio
2.152.153.425.097.989.28
Upgrade
Current Ratio
2.192.193.535.258.469.70
Upgrade
Return on Equity (ROE)
-89.62%-89.62%24.95%-56.53%-81.47%-75.77%
Upgrade
Return on Assets (ROA)
-30.93%-30.93%10.90%-12.91%-33.88%-38.10%
Upgrade
Return on Capital (ROIC)
-55.63%-55.63%17.17%-16.86%-38.73%-44.95%
Upgrade
Return on Capital Employed (ROCE)
--18.40%---
Upgrade
Earnings Yield
-173.74%-122.10%29.27%-51.82%-17.34%-14.85%
Upgrade
FCF Yield
-59.40%-41.75%-42.35%-8.63%-12.43%-16.32%
Upgrade
Buyback Yield / Dilution
-1.98%-1.98%-40.98%-21.65%-38.01%-23.27%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q